Korean Drug Co., Ltd. (KOSDAQ:014570)

South Korea · Delayed Price · Currency is KRW

3,360.00

+50.00 (1.51%)

At close: Jul 31, 2026

Korean Drug Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	62,760	62,509	73,001	81,375	79,984	74,466
Revenue Growth	-6.01%	-14.37%	-10.29%	1.74%	7.41%	11.49%
Gross Profit	27,434	26,601	34,401	37,350	34,517	31,065
Operating Income	7,285	6,913	4,105	6,720	14,329	11,266
Net Income	6,912	6,512	2,995	-4,917	11,809	9,042
Earnings Per Share	636.08	601.97	277.55	-455.98	1095.09	827.64
EPS Growth	1428.93%	116.89%	-	-	32.31%	22.18%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	34,540	29,996	19,000	16,756	26,416	27,881
Total Debt	83.07	57.84	80.97	67.57	81.2	54.07
Net Cash (Debt)	34,457	29,939	18,919	16,688	26,335	27,826
Net Cash Growth	34.16%	58.25%	13.37%	-36.63%	-5.36%	25.47%
Net Cash Per Share	3171.01	2767.49	1753.14	1547.64	2442.18	2546.94

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	11,100	13,110	4,869	-1,999	5,913	8,806
Capital Expenditures	-466.77	-457	-1,027	-120.7	-6,093	-1,146
Free Cash Flow	10,633	12,653	3,842	-2,119	-180.15	7,660
Free Cash Flow Growth	4.73%	229.34%	-	-	-	-33.92%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	43.71%	42.55%	47.12%	45.90%	43.16%	41.72%
Operating Margin	11.61%	11.06%	5.62%	8.26%	17.91%	15.13%
Pretax Margin	13.29%	12.47%	6.84%	10.16%	18.36%	15.20%
Profit Margin	11.01%	10.42%	4.10%	-6.04%	14.76%	12.14%
FCF Margin	16.94%	20.24%	5.26%	-2.60%	-0.22%	10.29%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	5.28	7.21	16.74	-	7.24	10.78
P/FCF Ratio	3.45	3.71	13.05	-	-	12.72
PS Ratio	0.58	0.75	0.69	0.96	1.07	1.31